Circumventing glucocorticoid-mediated hyperinsulinemia via the activation of PPARalpha. | Cell Cycle;8(15): 2311-2, 2009 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Circumventing glucocorticoid-mediated hyperinsulinemia via the activation of PPARalpha.

Bougarne, Nadia; Paumelle, Réjane; Haegeman, Guy; Staels, Bart; De Bosscher, Karolien.

Cell Cycle ; 8(15): 2311-2, 2009 Aug.

Article in En | MEDLINE | ID: mdl-19625768

Subject(s)

Fenofibrate/therapeutic use; Glucocorticoids/adverse effects; Hyperinsulinism/drug therapy; Hypolipidemic Agents/therapeutic use; PPAR alpha/agonists; Gene Expression; Glucocorticoids/antagonists & inhibitors; Humans; Hyperinsulinism/chemically induced; Neoplasms/drug therapy

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Fenofibrate / PPAR alpha / Glucocorticoids / Hyperinsulinism / Hypolipidemic Agents Limits: Humans Language: En Journal: Cell Cycle Year: 2009 Document type: Article

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Fenofibrate / PPAR alpha / Glucocorticoids / Hyperinsulinism / Hypolipidemic Agents Limits: Humans Language: En Journal: Cell Cycle Year: 2009 Document type: Article